| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 184,761 | 188,790 | 94,479 | 97,744 |
| Restricted cash | 114 | 113 | 113 | 113 |
| Trade and other receivables | 3 | 130 | 7 | 33 |
| Prepaid and other assets | 1,139 | 562 | 480 | 628 |
| Total current assets | 186,017 | 189,595 | 95,079 | 98,518 |
| Total property and equipment, gross | 1,416 | 1,612 | 1,601 | 1,601 |
| Accumulated depreciation and amortization | 1,300 | 1,497 | 1,483 | 1,470 |
| Property and equipment, net | 116 | 115 | 118 | 131 |
| Deposits | 55 | 55 | 55 | 55 |
| Prepaid and other assets | 12 | 11 | 20 | 28 |
| Right-of-use assets | 800 | 905 | 755 | 860 |
| Total assets | 187,000 | 190,681 | 96,027 | 99,592 |
| Trade and other payables | 2,251 | 1,850 | 1,148 | 1,022 |
| Accrued employee benefits | 541 | 483 | 463 | 426 |
| Lease liabilities, current portion | 482 | 468 | 414 | 354 |
| Total current liabilities | 3,274 | 2,801 | 2,025 | 1,802 |
| Non-current accrued employee benefits | NaN | NaN | NaN | 0 |
| Lease liabilities, less current portion | 394 | 519 | 403 | 495 |
| Total liabilities | 3,668 | 3,320 | 2,428 | 2,297 |
| Common stock, 0.0001 par value-160,000,000 shares authorized 34,354,334 and 26,250,469 shares issued and outstanding at march 31, 2026 and june 30, 2025, respectively | 3 | 3 | 2 | 2 |
| Additional paid-in capital | 445,194 | 437,219 | 331,488 | 326,308 |
| Accumulated deficit | -260,913 | -248,978 | -237,141 | -228,176 |
| Accumulated other comprehensive loss | -952 | -883 | -750 | -839 |
| Total stockholders' equity | 183,332 | 187,361 | 93,599 | 97,295 |
| Total liabilities and stockholders' equity | 187,000 | 190,681 | 96,027 | 99,592 |
Benitec Biopharma Inc. (BNTC)
Benitec Biopharma Inc. (BNTC)